News
Shortcuts from other journals
Alendronate combats skeletal side effects of antiandrogen therapy
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7595.661-b (Published 29 March 2007) Cite this as: BMJ 2007;334:661
Antiandrogen therapy may be an effective treatment for prostate cancer, but it has a detrimental effect on bone mineral density, which leads to osteoporosis and fractures. Men using gonadotrophin releasing hormone agonists, antiandrogens, or both, should …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.